Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Rünger

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 3, 2022
Immune checkpoint blockade for organ-transplant recipients with cancer: A reviewAlessandra Rünger, Dirk Schadendorf, Axel Hauschild, et al.
International Journal of Dermatology|March 20, 2024
Successful treatment of non-uremic calciphylaxis with combination therapy with sodium thiosulfate, iloprost, and heparinFinn Abeck, Inga Hansen, Alessandra Rünger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 17, 2023
Neoadjuvant cemiplimab induces durable complete response in locally advanced cutaneous squamous cell carcinomaGlenn Geidel, Laura Adam, Alessandra Rünger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 7, 2023
Sepsis-like cytokine release syndrome after application of tebentafusp in metastasized uveal melanomaGlenn Geidel, Finn Abeck, Inga Hansen, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 9, 2024
Severe overlap of morphea and lichen sclerosus after anti-PD-L1 immunotherapy in small cell lung cancerGlenn Geidel, Anne Menz, Franziska M Grotenrath, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 29, 2024
Prevention of amputation by neoadjuvant therapy with pembrolizumab in acrolentiginous melanomaInga Hansen, Alessandra Rünger, Clara Noebel, et al.
The Journal of Dermatology|November 18, 2024
Characterization of non-IgA vasculitis: Demographic, clinical, and treatment-related features in a retrospective analysis of 28 biopsy-confirmed cases from a German university hospitalInga Hansen-Abeck, Alessandra Rünger, Lisa Piepke, et al.
Journal of Cosmetic Dermatology|May 7, 2024
Patient-reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia: A retrospective study using telemedical dataFinn Abeck, Inga Hansen, Julian Kött, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 15, 2024
Differential predictive value of tissue-specific PD-L1 expression scores in adjuvant immunotherapy of melanomaGlenn Geidel, Niousha Parnian, Christian Meß, et al.
Cancers|July 12, 2025
Serum Complement Factor H: A Marker for Progression and Outcome Prediction Towards Immunotherapy in Cutaneous Squamous Cell CarcinomaGlenn Geidel, Laura Adam, Sabrina Bänsch, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|October 3, 2022
Immune checkpoint blockade for organ-transplant recipients with cancer: A reviewAlessandra Rünger, Dirk Schadendorf, Axel Hauschild, et al.
International Journal of Dermatology|March 20, 2024
Successful treatment of non-uremic calciphylaxis with combination therapy with sodium thiosulfate, iloprost, and heparinFinn Abeck, Inga Hansen, Alessandra Rünger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 17, 2023
Neoadjuvant cemiplimab induces durable complete response in locally advanced cutaneous squamous cell carcinomaGlenn Geidel, Laura Adam, Alessandra Rünger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 7, 2023
Sepsis-like cytokine release syndrome after application of tebentafusp in metastasized uveal melanomaGlenn Geidel, Finn Abeck, Inga Hansen, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 9, 2024
Severe overlap of morphea and lichen sclerosus after anti-PD-L1 immunotherapy in small cell lung cancerGlenn Geidel, Anne Menz, Franziska M Grotenrath, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 29, 2024
Prevention of amputation by neoadjuvant therapy with pembrolizumab in acrolentiginous melanomaInga Hansen, Alessandra Rünger, Clara Noebel, et al.
The Journal of Dermatology|November 18, 2024
Characterization of non-IgA vasculitis: Demographic, clinical, and treatment-related features in a retrospective analysis of 28 biopsy-confirmed cases from a German university hospitalInga Hansen-Abeck, Alessandra Rünger, Lisa Piepke, et al.
Journal of Cosmetic Dermatology|May 7, 2024
Patient-reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia: A retrospective study using telemedical dataFinn Abeck, Inga Hansen, Julian Kött, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 15, 2024
Differential predictive value of tissue-specific PD-L1 expression scores in adjuvant immunotherapy of melanomaGlenn Geidel, Niousha Parnian, Christian Meß, et al.
Cancers|July 12, 2025
Serum Complement Factor H: A Marker for Progression and Outcome Prediction Towards Immunotherapy in Cutaneous Squamous Cell CarcinomaGlenn Geidel, Laura Adam, Sabrina Bänsch, et al.
Pageof 3